ADIPOSA Study
Adipose Dysfunction, Imaging, Physiology, and Outcomes with SGLT2i’s for Sleep Apnea
GENDER: All
HEALTHY PARTICIPANTS: No
CONDITION: Sleep Apnea
COMPENSATION: Yes
Learn more about this research study
Please contact the study coordinator, Joseph Rutter, at 216-286-5025 for more information or complete the online form below.
Purpose of Study
The purpose of the study is to evaluate the effectiveness of an investigative medication, bexagliflozin, for obstructive sleep apnea (OSA).
Who Can Participate?
Participants 18 years and older that are overweight or obese (body mass index 25-40 kg/m2) and have a clinically confirmed diagnosis of obstructive sleep apnea may be eligible for this study.
Study Details
The study participation will last approximately six months with five visits to the hospital. These visits will take about 12-hours total. Study procedures will include sleep studies, questionnaires, two MRI scans, wearing an activity tracker, blood pressure monitoring, and laboratory tests.